Elevation Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.6K Buy
105
+90
+600% +$33.4K 0.01% 360
2026
Q1
$4.4K Sell
15
-4
-21% -$1.31K ﹤0.01% 741
2025
Q4
$6.67K Buy
19
+7
+58% +$2.37K ﹤0.01% 564
2025
Q3
$3.88K Buy
+12
New +$3.73K ﹤0.01% 525
2025
Q2
Hold
0
480
2025
Q1
Hold
0
488
2024
Q4
Hold
0
495
2024
Q3
Hold
0
471
2024
Q2
Hold
0
500
2024
Q1
Hold
0
470
2023
Q4
Hold
0
438
2023
Q3
Hold
0
339
2023
Q2
Hold
0
352
2023
Q1
Hold
0
347

Other funds holding ELV

Elevation Wealth Partners's ELV Position: Q2 2026 in Review

Elevation Wealth Partners increased its Elevance Health (ELV) stake by 600% in Q2 2026, buying an estimated $33.4K and bringing the position to 105 shares worth $40.6K. The position accounts for 0.01% of the portfolio, ranked #360.

Elevation Wealth Partners first reported a position in ELV in Q3 2025 and has held it in 4 quarters since. 582 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Elevation Wealth Partners held 105 shares of Elevance Health worth $40.6K as of Q2 2026.
  • Elevation Wealth Partners bought 90 Elevance Health shares in Q2 2026, an estimated $33.4K.
  • Elevance Health made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #360 holding.
  • Elevation Wealth Partners first reported a position in Elevance Health in Q3 2025 and has held it in 4 quarters since.
  • 582 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.